TREVENA, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-12-17: Reporting owner Bourdow Carrie L.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-12-17: Reporting owner Applebaum Scott; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-12-17: Reporting owner Yoder Robert T; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-12-17: Reporting owner Demitrack Mark; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-17 | Bourdow Carrie L. Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +706,650 706,650 owned after | $2.25 exercise price | 2020-12-18 | |
| 2020-12-17 | Applebaum Scott Officer (CLCO; SVP, Regulatory Affairs) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +172,750 172,750 owned after | $2.25 exercise price | 2020-12-18 | |
| 2020-12-17 | Yoder Robert T Officer (SVP, Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +212,000 212,000 owned after | $2.25 exercise price | 2020-12-18 | |
| 2020-12-17 | Demitrack Mark Officer (Sr. VP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +259,100 259,100 owned after | $2.25 exercise price | 2020-12-18 | |
| 2020-12-17 | Shin Barry Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +235,550 235,550 owned after | $2.25 exercise price | 2020-12-18 | |
| 2020-10-02 | Yoder Robert T Officer (Sr. VP, Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +59,000 59,000 owned after | $2.90 exercise price | 2020-10-08 | |
| 2020-05-13 | Yanni Barbara Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,103 64,103 owned after | $1.05 exercise price | 2020-05-15 | |
| 2020-05-13 | Phillips Anne M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,103 64,103 owned after | $1.05 exercise price | 2020-05-15 | |
| 2020-05-13 | Nunn Jason Raleigh Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,103 64,103 owned after | $1.05 exercise price | 2020-05-15 | |
| 2020-05-13 | MOULDER LEON O JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,103 64,103 owned after | $1.05 exercise price | 2020-05-15 | |
| 2020-05-13 | McHugh Julie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,103 64,103 owned after | $1.05 exercise price | 2020-05-15 | |
| 2020-05-13 | GOWEN MAXINE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,103 64,103 owned after | $1.05 exercise price | 2020-05-15 | |
| 2020-05-13 | DOUGHERTY MICHAEL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,103 64,103 owned after | $1.05 exercise price | 2020-05-15 | |
| 2020-05-13 | Braunstein Scott Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,103 64,103 owned after | $1.05 exercise price | 2020-05-15 | |
| 2020-02-10 | Applebaum Scott Officer (CLCO; SVP Regulatory Affairs) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.79 exercise price | 2020-02-12 |